A phase II trial of first-line sorafenib in patients with metastatic renal cell carcinoma unwilling to receive or with early intolerance to immunotherapy: SOGUG Study 06-01
Clin. transl. oncol. (Print)
; 12(7): 503-508, jul. 2010. tab, ilus
Article
em En
| IBECS
| ID: ibc-124105
Biblioteca responsável:
ES1.1
Localização: BNCS
ABSTRACT
AIMS: Our aim was to evaluate first-line treatment of metastatic renal cell carcinoma (mRCC) with sorafenib in patients unwilling to receive immunotherapy or with early in
Buscar no Google
Coleções:
06-national
/
ES
Base de dados:
IBECS
Assunto principal:
Piridinas
/
Benzenossulfonatos
/
Carcinoma de Células Renais
/
Neoplasias Renais
/
Antineoplásicos
Limite:
Aged
/
Female
/
Humans
/
Male
Idioma:
En
Revista:
Clin. transl. oncol. (Print)
Ano de publicação:
2010
Tipo de documento:
Article